Genzyme CorporateSearchGenzyme Websites
MPSI Disease Treatment Information for Patients and FamiliesMPSI Disease Treatment Information for Health Care Providers
MPSI
Health Care Professionals
Disease Overview
Genetics and MPS I
Severe and Attenuated
Symptoms & Symptom Management
Disease Progression
The MPS Family of Diseases
Lysosomal Storage Disorders
Diagnosing MPS I
Treatment Options
The MPS I Registry
Resources and Support

Gastrointestinal System

General Physical Appearance
Nervous System

Skeletal System

Respiratory System

Auditory System

Cardiovascular System

Ocular System

Gastrointestinal System

Protuberance of the abdomen is commonly observed in patients with severe MPS I and is caused by the progressive hepatosplenomegaly.[1] Many children with severe MPS I suffer periodically from loose stools and diarrhea, sometimes alternating with periods of severe constipation due to storage within ganglion cells of the enteric nervous system. These problems may or may not diminish as the child gets older; they are exacerbated by muscle weakness and diminished physical activity (which progress with age) as well as antibiotic use for
other problems.[2]

Individuals with attenuated MPS I on clinical examination tend to exhibit variable protuberance of the abdomen as a result of an enlarged liver, but their spleens may be normal. Hernias occur in attenuated patients perhaps less frequently than in severe patients.[2]

Umbilical hernias (Image 1) are generally not treated unless they are exceedingly large and cause problems. Some gastrointestinal symptoms (diarrhea and constipation) can be controlled by diet – including control of the amount of roughage. Increased roughage and the conservative use of laxatives may help with constipation.

An individual affected by MPS I with an umbilical hernia
An individual affected by MPS I with an umbilical hernia

Courtesy of Hodder/Arnold Publishers

References:

1. Clarke, L.A. (1997) Clinical diagnosis of lysosomal storage diseases. In: Organelle Diseases. Clinical Features, Diagnosis, Pathogenesis and Management. Applegarth, D.A., Dimmick, J.E., and Hall, J.G. (eds.). Chapman and Hall Medical, London, pp. 37.

2. Clarke, L.A. and MacFarland, J. 2001 Mucopolysaccharidosis-I (MPS-I). The Canadian Society for Mucopolysaccharide and Related Diseases, Inc., Clarke, L.A., Kaweski, C., Di Ilio, L., and Hahn, S. (eds.). Ticky Graphics & Printing, Vancouver.

Did you know...
In MPS I, glycosaminoglycan (GAG)-engorged cells accumulate and displace healthy normal cells in tissue and organs such as the liver and spleen, causing a host of signs, including skeletal deformities, coarse facial features, and an enlarged liver and spleen.
Watch Video
Alicia is a 16-year-old with MPS I who was diagnosed 10 years ago. Watch Alicia’s story to find out how she is handling life as a teenager living with MPS I.
Watch the Video
Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142 USA
Phone: 617-768-9000 or
800-745-4447
Contact Genzyme